Article Details
Retrieved on: 2021-10-11 10:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production.
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here